Showing results (2151-2160 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 2, 2020
COVID-19 human challenge studies: ethical issuesEuzebiusz Jamrozik, Michael J Selgelid
The Lancet. Infectious Diseases|October 21, 2019
Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trialStijn F H Raven, Christian J P A Hoebe, Ann C T M Vossen, et al.
The Lancet. Infectious Diseases|June 12, 2015
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trialJosé A Perez-Molina, Rafael Rubio, Antonio Rivero, et al.
The Lancet. Infectious Diseases|July 19, 2015
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort studyAnita Kohli, Rama Kapoor, Zayani Sims, et al.
The Lancet. Infectious Diseases|June 3, 2020
Cavitary tuberculosis: the gateway of disease transmissionMichael E Urbanowski, Alvaro A Ordonez, Camilo A Ruiz-Bedoya, et al.
The Lancet. Infectious Diseases|February 16, 2023
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort studyCarlos K H Wong, Kristy T K Lau, Ivan C H Au, et al.
The Lancet. Infectious Diseases|November 10, 2016
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysisTimothy Lawes, José-María Lopez-Lozano, Cesar A Nebot, et al.
The Lancet. Infectious Diseases|November 15, 2016
Does antimalarial mass drug administration increase or decrease the risk of resistance?Nicholas J White
The Lancet. Infectious Diseases|November 22, 2016
A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might failDebra A Goff, Ravina Kullar, Ellie J C Goldstein, et al.
The Lancet. Infectious Diseases|December 5, 2016
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort studyJohn Gregson, Pontiano Kaleebu, Vincent C Marconi, et al.
Pageof 270